Literature DB >> 16269615

AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies.

Gerhard Moldenhauer1, Sergey W Popov, Beate Wotschke, Silke Brüderlein, Petra Riedl, Nicolas Fissolo, Reinhold Schirmbeck, Olga Ritz, Peter Möller, Frank Leithäuser.   

Abstract

Neoplastic transformation of mature B cells can be triggered by class-switch recombination of the immunoglobulin gene, which aberrantly targets a protooncogene and promotes translocation. Class-switch recombination is initiated by the B-cell-specific protein activation-induced cytidine deaminase (AID). Using immunohistochemistry with a newly generated monoclonal antibody and quantitative reverse-transcription-polymerase chain reaction (RT-PCR) on microdissected tissue from lymph node, tonsil, and thymus, we demonstrate that AID expression is found in secondary lymphoid organs outside germinal centers and in the thymic medulla at substantial levels. This is accompanied by the presence of circle transcripts, indicating class-switch recombination to be active at these sites. The dominant AID-expressing cell population outside germinal centers displays cytomorphologic properties corresponding to those that define the recently characterized interfollicular large B-cell subset. These findings indicate that interfollicular large B cells and AID-expressing B lymphocytes of the thymic medulla could give rise to mature B-cell malignancies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269615     DOI: 10.1182/blood-2005-06-2502

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Germinal-center organization and cellular dynamics.

Authors:  Christopher D C Allen; Takaharu Okada; Jason G Cyster
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

Review 2.  Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Adam Bagg
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

Review 3.  Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.

Authors:  Pier Luigi Zinzani; Pier Paolo Piccaluga
Journal:  Curr Oncol Rep       Date:  2011-10       Impact factor: 5.075

4.  Ectopic lymphoid structures in primary cutaneous melanoma.

Authors:  Andrea Ladányi; Tímea Sebestyén; Anita Mohos; Gabriella Liszkay; Beáta Somlai; Erika Tóth; József Tímár
Journal:  Pathol Oncol Res       Date:  2014-04-30       Impact factor: 3.201

Review 5.  Human memory B cells.

Authors:  M Seifert; R Küppers
Journal:  Leukemia       Date:  2016-08-08       Impact factor: 11.528

6.  Regulation of AID expression in the immune response.

Authors:  Elizabeth E Crouch; Zhiyu Li; Makiko Takizawa; Stefan Fichtner-Feigl; Polyxeni Gourzi; Carolina Montaño; Lionel Feigenbaum; Patrick Wilson; Siegfried Janz; F Nina Papavasiliou; Rafael Casellas
Journal:  J Exp Med       Date:  2007-04-23       Impact factor: 14.307

7.  Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.

Authors:  Olga Ritz; Chrystelle Guiter; Flavia Castellano; Karola Dorsch; Julia Melzner; Jean-Philippe Jais; Gwendoline Dubois; Philippe Gaulard; Peter Möller; Karen Leroy
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

8.  Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting.

Authors:  Nancy S Longo; Patricia L Lugar; Sule Yavuz; Wen Zhang; Peter H L Krijger; Daniel E Russ; Dereje D Jima; Sandeep S Dave; Amrie C Grammer; Peter E Lipsky
Journal:  Blood       Date:  2008-11-20       Impact factor: 22.113

Review 9.  Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer.

Authors:  Diana Mechtcheriakova; Martin Svoboda; Anastasia Meshcheryakova; Erika Jensen-Jarolim
Journal:  Cancer Immunol Immunother       Date:  2012-04-19       Impact factor: 6.968

10.  Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.

Authors:  Frances Humby; Michele Bombardieri; Antonio Manzo; Stephen Kelly; Mark C Blades; Bruce Kirkham; Jo Spencer; Costantino Pitzalis
Journal:  PLoS Med       Date:  2009-01-13       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.